These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 26545873)

  • 1. Inter- and intrasubject variability of the inflammatory response to segmental endotoxin challenge in healthy volunteers.
    Holz O; Tan L; Schaumann F; Müller M; Scholl D; Hidi R; McLeod A; Krug N; Hohlfeld JM
    Pulm Pharmacol Ther; 2015 Dec; 35():50-9. PubMed ID: 26545873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of bradykinin 1 receptor antagonist BI 1026706 on pulmonary inflammation after segmental lipopolysaccharide challenge in healthy smokers.
    Gress C; Vogel-Claussen J; Badorrek P; Müller M; Hohl K; Konietzke M; Litzenburger T; Seibold W; Gupta A; Hohlfeld JM
    Pulm Pharmacol Ther; 2023 Oct; 82():102246. PubMed ID: 37562641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigating the effect of TRPV4 inhibition on pulmonary-vascular barrier permeability following segmental endotoxin challenge.
    Mole S; Harry A; Fowler A; Hotee S; Warburton J; Waite S; Beerahee M; Behm DJ; Badorrek P; Müller M; Faulenbach C; Lazaar AL; Hohlfeld JM
    Pulm Pharmacol Ther; 2020 Oct; 64():101977. PubMed ID: 33189900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptomic characterization of the human segmental endotoxin challenge model.
    Gress C; Litzenburger T; Schmid R; Xiao K; Heissig F; Muller M; Gupta A; Hohlfeld JM
    Sci Rep; 2024 Jan; 14(1):1721. PubMed ID: 38242945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Roflumilast attenuates pulmonary inflammation upon segmental endotoxin challenge in healthy subjects: a randomized placebo-controlled trial.
    Hohlfeld JM; Schoenfeld K; Lavae-Mokhtari M; Schaumann F; Mueller M; Bredenbroeker D; Krug N; Hermann R
    Pulm Pharmacol Ther; 2008 Aug; 21(4):616-23. PubMed ID: 18374614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipopolysaccharide (LPS) inhalation in healthy subjects increases neutrophils, lymphocytes and fibronectin levels in bronchoalveolar lavage fluid.
    Sandström T; Bjermer L; Rylander R
    Eur Respir J; 1992 Sep; 5(8):992-6. PubMed ID: 1426208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of inhaled nanoparticles on acute lung injury induced by lipopolysaccharide in mice.
    Inoue K; Takano H; Yanagisawa R; Hirano S; Kobayashi T; Fujitani Y; Shimada A; Yoshikawa T
    Toxicology; 2007 Sep; 238(2-3):99-110. PubMed ID: 17614186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-dose endotoxin inhalation in healthy volunteers--a challenge model for early clinical drug development.
    Janssen O; Schaumann F; Holz O; Lavae-Mokhtari B; Welker L; Winkler C; Biller H; Krug N; Hohlfeld JM
    BMC Pulm Med; 2013 Mar; 13():19. PubMed ID: 23537365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes of breath volatile organic compounds in healthy volunteers following segmental and inhalation endotoxin challenge.
    Holz O; van Vorstenbosch R; Guenther F; Schuchardt S; Trinkmann F; van Schooten FJ; Smolinska A; Hohlfeld JM
    J Breath Res; 2022 May; 16(3):. PubMed ID: 35366648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of organic chemicals derived from ambient particulate matter on lung inflammation related to lipopolysaccharide.
    Inoue K; Takano H; Yanagisawa R; Hirano S; Kobayashi T; Ichinose T; Yoshikawa T
    Arch Toxicol; 2006 Dec; 80(12):833-8. PubMed ID: 16639588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PA401, a novel CXCL8-based biologic therapeutic with increased glycosaminoglycan binding, reduces bronchoalveolar lavage neutrophils and systemic inflammatory markers in a murine model of LPS-induced lung inflammation.
    Adage T; Del Bene F; Fiorentini F; Doornbos RP; Zankl C; Bartley MR; Kungl AJ
    Cytokine; 2015 Dec; 76(2):433-441. PubMed ID: 26303011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-dose endotoxin elicits variability in the inflammatory response in healthy volunteers.
    Stephens RC; O'Malley CM; Frumento RJ; Mythen MG; Bennett-Guerrero E
    J Endotoxin Res; 2005; 11(4):207-12. PubMed ID: 16176656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activated pulmonary vascular neutrophils as early mediators of endotoxin-induced lung inflammation.
    Williams JH; Patel SK; Hatakeyama D; Arian R; Guo K; Hickey TJ; Liao SY; Ulich TR
    Am J Respir Cell Mol Biol; 1993 Feb; 8(2):134-44. PubMed ID: 8381291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of neutrophils in LPS-induced changes in pulmonary function in conscious rats.
    Spond J; Billah MM; Chapman RW; Egan RW; Hey JA; House A; Kreutner W; Minnicozzi M
    Pulm Pharmacol Ther; 2004; 17(3):133-40. PubMed ID: 15123222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of neutrophil apoptosis and secondary necrosis during endotoxin-induced pulmonary inflammation in mice.
    Medan D; Wang L; Yang X; Dokka S; Castranova V; Rojanasakul Y
    J Cell Physiol; 2002 Jun; 191(3):320-6. PubMed ID: 12012327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammatory cytokines can be monitored in exhaled breath particles following segmental and inhalation endotoxin challenge in healthy volunteers.
    Holz O; Müller M; Carstensen S; Olin AC; Hohlfeld JM
    Sci Rep; 2022 Apr; 12(1):5620. PubMed ID: 35379863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pleiotropic effects of angiopoietin-2 deficiency do not protect mice against endotoxin-induced acute kidney injury.
    Kurniati NF; van Meurs M; Vom Hagen F; Jongman RM; Moser J; Zwiers PJ; Struys MM; Westra J; Zijlstra JG; Hammes HP; Molema G; Heeringa P
    Nephrol Dial Transplant; 2013 Mar; 28(3):567-75. PubMed ID: 22872727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipopolysaccharide-induced lung injury in mice. I. Concomitant evaluation of inflammatory cells and haemorrhagic lung damage.
    Asti C; Ruggieri V; Porzio S; Chiusaroli R; Melillo G; Caselli GF
    Pulm Pharmacol Ther; 2000; 13(2):61-9. PubMed ID: 10799283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Airway inflammation and responsiveness in prostaglandin H synthase-deficient mice exposed to bacterial lipopolysaccharide.
    Zeldin DC; Wohlford-Lenane C; Chulada P; Bradbury JA; Scarborough PE; Roggli V; Langenbach R; Schwartz DA
    Am J Respir Cell Mol Biol; 2001 Oct; 25(4):457-65. PubMed ID: 11694451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FDG-PET imaging of pulmonary inflammation in healthy volunteers after airway instillation of endotoxin.
    Chen DL; Rosenbluth DB; Mintun MA; Schuster DP
    J Appl Physiol (1985); 2006 May; 100(5):1602-9. PubMed ID: 16424067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.